Pasar al contenido principal

EL SISTEMA “MISMATCH REPAIR” MICOBACTERIANO Y LA EVOLUCION HACIA LA RESISTENCIA A ANTIBIOTICOS EN MYCOBACTERIUM TUBERCULOSIS

PID2020-112865RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes

  • Cebrián-Sastre, E.
  • Chiner-Oms, Álvaro
  • Torres-Pérez, Rafael
  • Comas, Iñaki
  • Oliveros, Juan C.
  • Blázquez, J.
  • Castañeda-García, Alfredo
20 páginas, 8 figuras, 2 tablas. Material suplementario accesible solo online, Resistance to the frontline antibiotic rifampicin constitutes a challenge to the treatment and control of tuberculosis. Here, we analyzed the mutational landscape of Mycobacterium smegmatis during long-term evolution with increasing concentrations of rifampicin, using a mutation accumulation assay combined with whole-genome sequencing. Antibiotic treatment enhanced the acquisition of mutations, doubling the genome-wide mutation rate of the wild-type cells. While antibiotic exposure led to extinction of almost all wild-type lines, the hypermutable phenotype of the ΔnucS mutant strain (noncanonical mismatch repair deficient) provided an efficient response to the antibiotic, leading to high rates of survival. This adaptative advantage resulted in the emergence of higher levels of rifampicin resistance, an accelerated acquisition of drug resistance mutations in rpoB (β RNA polymerase), and a wider diversity of evolutionary pathways that led to drug resistance. Finally, this approach revealed a subset of adaptive genes under positive selection with rifampicin that could be associated with the development of antibiotic resistance. IMPORTANCE Rifampicin is the most important first-line antibiotic against mycobacterial infections, including tuberculosis, one of the top causes of death worldwide. Acquisition of rifampicin resistance constitutes a major global public health problem that makes the control of the disease challenging. Here, we performed an experimental evolution assay under antibiotic selection to analyze the response and adaptation of mycobacteria, leading to the acquisition of rifampicin resistance. This approach explored the total number of mutations that arose in the mycobacterial genomes under long-term rifampicin exposure, using whole-genome sequencing. Our results revealed the effect of rifampicin at a genomic level, identifying different mechanisms and multiple pathways leading to rifampicin resistance in mycobacteria. Moreover, this study detected that an increase in the rate of mutations led to enhanced levels of drug resistance and survival. In summary, all of these results could be useful to understand and prevent the emergence of drug-resistant isolates in mycobacterial infections., This research was funded by MCIN/AEI/10.13039/501100011033, grant PID2020- 112865RB-I00, and Instituto de Salud Carlos III, grant FIS PI17/00159 (ISCIII/FEDER, UE). E.C.-S. is the recipient of a PFIS predoctoral research fellowship (FI18/00036) cofinanced by the Instituto de Salud Carlos III and the European Social Fund. A.C.-G. acknowledges financial support from the Spanish State Research Agency, AEI/10.13039/501100011033, through the “Severo Ochoa” Program for Centers of Excellence in R&D (SEV-2013-0347, SEV-2017-0712), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microevolution, reinfection and highly complex genomic diversity in patients with sequential isolates of Mycobacterium abscessus

  • Buenestado-Serrano, Sergio
  • Martínez-Lirola, Miguel
  • Herranz-Martín, Marta
  • Esteban, Jaime
  • Broncano-Lavado, Antonio
  • Molero-Salinas, Andrea
  • Sanz-Pérez, Amadeo
  • Blázquez Gómez, Jesús
  • Ruedas-López, Alba
  • Toro, Carlos
  • López-Roa, Paula
  • Domingo, Diego
  • Zamarrón, Ester
  • Ruiz Serrano, María Jesús
  • Muñoz, Patricia
  • Pérez-Lago, Laura
  • García de Viedma, Darío
Mycobacterium abscessus is an opportunistic, extensively drug-resistant non-tuberculous mycobacterium. Few genomic studies consider its diversity in persistent infections. Our aim was to characterize microevolution/reinfection events in persistent infections. Fifty-three sequential isolates from 14 patients were sequenced to determine SNV-based distances, assign resistance mutations and characterize plasmids. Genomic analysis revealed 12 persistent cases (0-13 differential SNVs), one reinfection (15,956 SNVs) and one very complex case (23 sequential isolates over 192 months), in which a first period of persistence (58 months) involving the same genotype 1 was followed by identification of a genotype 2 (76 SNVs) in 6 additional alternating isolates; additionally, ten transient genotypes (88-243 SNVs) were found. A macrolide resistance mutation was identified from the second isolate. Despite high diversity, the genotypes shared a common phylogenetic ancestor and some coexisted in the same specimens. Genomic analysis is required to access the true intra-patient complexity behind persistent infections involving M. abscessus., This work was supported by the Instituto de Salud Carlos III [AC16/00057, FIS15/01554, PI21/01823, PI19/00331, FI20/00129, PI21/01738], co-financed by European Regional Development Funds of the European Commission: “A way of making Europe”; a Miguel Servet Contract (ISCIII) CPII20/00001 to LPL. FI22/00145 contract from a PFIS (ISCIII) to SBS and Ministerio de Ciencia (MCIN/AEI/10.13039/501100011033, grant PID2020-112865RB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The emergence of resistance to the antiparasitic selamectin in Mycobacterium smegmatis is improbable and contingent on cell wall integrity

  • Ezquerra-Aznárez, José Manuel
  • Gasparovic, Henrich
  • Chiner-Oms, Álvaro
  • Lucía, Ainhoa
  • Blázquez, Jesús
  • Comas, Iñaki
  • Kordulákova, Jana
  • Aínsa, José A.
  • Ramón-García, Santiago
18 páginas, 6 figuras, 4 tablas, Tuberculosis remains the deadliest infectious disease of the 21st century. New antimicrobials are needed to improve treatment outcomes and enable therapy shortening. Drug repurposing is an alternative to the traditional drug discovery process. The avermectins are a family of macrocyclic lactones with anthelmintic activity active against Mycobacterium tuberculosis. However, their mode of action in mycobacteria remains unknown. In this study, we employed traditional mutant isolation approaches using Mycobacterium smegmatis, a non-pathogenic M. tuberculosis surrogate. We were only able to isolate mutants with decreased susceptibility to selamectin using the ∆nucS mutator M. smegmatis strain. This phenotype was caused by mutations in mps1 and mmpL11. Two of these mutants were used for a second experiment in which high-level selamectin-resistant mutants were isolated; however, specific mutations driving the phenotypic change to high-level resistance could not be identified. The susceptibility to selamectin in these mutants was restored to the basal level by subinhibitory concentrations of ethambutol. The selection of ethambutol resistance in a high-level selamectin-resistant mutant also resulted in multiple colonies becoming susceptible to selamectin again. These colonies carried mutations in embB, suggesting that the integrity of the cell envelope is a prerequisite for selamectin resistance. The absence of increased susceptibility to selamectin in an embB deletion strain demonstrated that the target of selamectin is not cytosolic. Our data show that the concurrence of specific multiple mutations and complete integrity of the mycobacterial envelope are necessary for selamectin resistance. Our studies provide first-time insights into the antimycobacterial mode of action of the antiparasitic avermectins.IMPORTANCETuberculosis is the deadliest infectious disease of the 21st century. New antibiotics are needed to improve treatment. However, developing new drugs is costly and lengthy. Drug repurposing is an alternative to the traditional drug discovery process. The avermectins are a family of drugs used to treat parasitic infections that are active against Mycobacterium tuberculosis, the bacterium that causes tuberculosis. However, their mode of action in mycobacteria remains unknown. Understanding how avermectins kill mycobacteria can facilitate its development as an anti-mycobacterial drug, including against M. tuberculosis.In this study, we used Mycobacterium smegmatis, a non-pathogenic M. tuberculosis surrogate model to understand the molecular mechanisms of how selamectin (a drug of the avermectin family selected for this study as a model) acts against mycobacteria. Our data show that the generation of resistance to selamectin is unlikely and that complete integrity of the mycobacterial envelope is necessary for selamectin resistance, providing first-time insights into the antimycobacterial mode of action of the avermectins., This research was supported by internal group funding (J.A.A. and S.R.-G) and by a fellowship from the Spanish Government (Programa de Formación de Profesorado Universitario) Ref. FPU18/03873 to J.M.E.-A. J.M.E.-A. also received support for a short-term stage from the Red Temática de Excelencia de Biología de Sistemas de Micobacterias (Myconet) to I.C. J.B. received funding from Ministerio de Ciencia (MCIN/AEI/10.13039/501100011033) (Grant PID2020-112865RB-I00). J.K. received funding from the Slovak Research and Development Agency [grant n. APVV-19-0189] and the OPII, ACCORD, ITMS2014+: 313021X329, co-financed by ERDF., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Regulation of the Expression of nucS, a Key Component of the Mismatch Repair System in Mycobacteria

  • Cebrián-Sastre, Esmeralda
  • Ruiz Enamorado, Ángel
  • Castañeda-García, Alfredo
  • Gola, Susanne
  • García-Bravo, Pablo
  • Kremer, Leonor
  • Blázquez, Jesús
Mismatch repair (MMR) system alterations can trigger transient hypermutation, promoting adaptive mutations under stress, such as antibiotic exposure. While most organisms use MutS and MutL protein families for MMR, many archaea and actinobacteria, including the major human pathogen Mycobacterium tuberculosis, lack these components and instead rely on NucS, a structurally distinct enzyme driving a non-canonical MMR pathway. Given the role of MMR in mutation control, understanding how nucS expression is regulated could be essential for uncovering the molecular basis of antibiotic resistance development in mycobacteria. In this study, we characterized the nucS promoter and transcription start site in Mycobacterium smegmatis. We found that nucS expression declines during the stationary phase in both M. smegmatis and M. tuberculosis, paralleling replication activity and canonical MMR downregulation. Our data suggest that the alternative sigma factor σB may negatively regulate nucS expression during this phase. Additionally, we identified candidate compounds that may modulate nucS expression, underscoring its responsiveness to environmental cues. These findings enhance our understanding of mycobacterial stress responses and lay the groundwork for exploring antibiotic resistance mechanisms. Strikingly, our work reveals a case of double convergent evolution: both canonical (MutS/MutL) and non-canonical (NucS) pathways have independently evolved not only the same DNA repair function, but also similar regulatory frameworks for genome integrity preservation under stress conditions., This research was funded by grants PCI2019-103488/AEI/10.13039/501100011033 and PID2020-112865RBI00/AEI/10.13039/501100011033 from the State Research Agency (AEI), and FIS PI17/00159 from the Carlos III Institute of Health (ISCIII) and the European Regional Development Fund (FEDER, EU). E.C.-S. is the recipient of a PFIS predoctoral fellowship (FI18/00036), co-funded by the ISCIII and the European Social Fund. Á.R.-E. is the recipient of an FPU fellowship from the Ministry of Science, Innovation and Universities (FPU2020/01676)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The unique role of nucS-mediated noncanonical mismatch repair in Mycobacterium tuberculosis resistance evolution

  • Martín-Blecua, Isabel
  • Sastre-Domínguez, Jorge
  • Valverde, José R.
  • García-Bravo, Pablo
  • Ruíz Enamorado, Ángel
  • Prados-Rosales, Rafael
  • Das, Lahari
  • Jacobs, William R
  • San Millán, Álvaro
  • Blázquez, Jesús
  • Gullón Blanco, Sonia
DNA surveillance mechanisms are crucial for maintaining genome stability and minimizing mutation rates. Mismatch repair (MMR) corrects replication errors that escape DNA-polymerase proofreading. In most organisms, MMR is orchestrated by MutS and MutL proteins. However, certain Archaea and Actinobacteria, including the major human pathogen Mycobacterium tuberculosis, lack these components. Instead, they appear to rely on the nuclease EndoMS/NucS, a structurally distinct enzyme governing a non-canonical MMR pathway. Since M. tuberculosis acquires drug resistance exclusively through chromosomal mutations, understanding its mutation rate regulation is critical. Nevertheless, the role of NucS in drug resistance evolution remains largely unexplored. We investigated NucS function in M. tuberculosis and uncovered a unique resistance dynamic distinct from other Actinobacteria. Deleting nucS altered the mutational spectrum but had minimal impact on the emergence of antibiotic-resistant mutants, contrasting sharply with other Actinobacteria where nucS loss dramatically increases mutation rates. This atypical behavior cannot be attributed solely to the R144S NucS polymorphism present in the H37Rv reference strain. Introducing the consensus NucS sequence in H37Rv produced only subtle changes in mutational spectrum without major effects on mutation rates. Analysis of 44,921 M. tuberculosis genomes revealed that most R144S-containing strains belong to the Euro-American sub-lineage 4.9, with no significant association with antibiotic resistance. However, nucS is under strong purifying selection, and R144S changes arose independently during M. tuberculosis evolution (homoplasy). Overall, our findings challenge the view that nucS serves as a genome stability guardian in M. tuberculosis and suggest additional mismatch repair mechanism(s) beyond NucS in this pathogen.IMPORTANCEDNA repair systems are crucial for maintaining the integrity of genetic information by scanning and correcting errors that arise during DNA replication. Most organisms use well-characterized proteins (MutS and MutL) for this task, but some bacteria and archaea, including most Actinobacteria, lack these conventional components. Instead, they employ an alternative enzyme, NucS, to fix replicative DNA errors. This alternative pathway is thought to limit harmful mutations and, in turn, reduce the likelihood of drug resistance development. In our study of Mycobacterium tuberculosis, the pathogen responsible for tuberculosis, we found that NucS plays only a minor role in preventing resistance-associated mutations. This unexpected result challenges current assumptions about DNA repair in this pathogen and points to the existence of other, yet unidentified mechanisms that safeguard its genome. Understanding these processes could open new avenues for therapeutic strategies against tuberculosis, a disease that remains a major global health threat., This research was supported by Ministerio de Ciencia (MCIN/AEI/10.13039/501100011033) (Grant PID2020-112865RB-I00). I.M.-B. was supported by the PRE2021-099108 grant, funded by MCIN/AEI/10.13039/501100011033 and the FSE+. A.S.M. and J.S.-D. were supported by the European Research Council (ERC) under the European Union’s Horizon Europe research and innovation program (ERC-2022-CoG Project 101086992–PLAS-FIGHTER). R.P.-R. acknowledges support by MINECO/FEDER EU contracts PID2022-136611OB-I00 and NIH-R01AI162821., Peer reviewed, Sin uso de modelos vivos
Docta Complutense
Publicación Artículo científico (JournalArticle)

First full‐vector archeomagnetic data from Central Asia (3 BCE to 15 CE centuries): evidence for a large non‐dipole field contribution around the first century BCE

  • Bonilla Alba, Raquel
  • Gómez Paccard, M.
  • Pavón Carrasco, Francisco Javier
  • Arquero Campuzano, Saioa
  • Beamud, E.
  • Martínez-Ferreras, V.
  • Gurt-Esparraguera, J. M.
  • Ariño-Gil, E.
  • Martín Hernández, Fátima
  • Osete López, María Luisa
Unraveling the short-term behavior of the Earth's past geomagnetic field at regional scales is crucial for understanding its global behavior and, thus, the dynamics of the deep Earth. In this context, obtaining accurate full-vector geomagnetic field records from regions where archeomagnetic data are absent becomes essential. Here, we present the first full-vector archeomagnetic data from Central Asia, derived from the analysis of nine archeological kilns sampled in South Uzbekistan, dating back to the period between 200 BCE and 1429 CE. To obtain these new data, we conducted thermal and alternating field demagnetization procedures, along with Thellier-Thellier paleointensity experiments, including partial thermoremanent magnetization checks, thermoremanent magnetization anisotropy and cooling rate corrections. The comparison between the new data, previous selected data from Central Asia, and available global models reveals important differences between approximately 400 BCE and 400 CE, especially concerning the geomagnetic field intensity element. In order to investigate this in detail, we have developed a regional update of the SHAWQ global models family by incorporating, for the first time, high-quality data from Central Asia. The results suggest that this deviation is linked to non-dipolar sources of the geomagnetic field in Central Asia reaching a maximum contribution around the first century BCE. According to the updated global paleoreconstruction, this non-dipole feature, manifested at the Earth's surface as low intensities, is associated with the presence of a reversed flux patch at the core-mantle boundary beneath this region. The geomagnetic field is a global feature that changes over time and space. These changes are known over the last few centuries through direct observations collected by satellites and geomagnetic observatories. However, indirect measurements, based on the paleomagnetic study of archeological and geological materials, are needed to disentangle geomagnetic field behavior over longer time scales. In this context, archeomagnetism is the discipline that studies the direction and strength of the past geomagnetic field by investigating the magnetic properties of well dated archeological baked clay material. In order to properly describe the behavior of the Earth's magnetic field it is crucial to have a good temporal and spatial coverage of archeomagnetic data. In this work, we present the first full-vector archeomagnetic data for Central Asia, a large region that remained unexplored from an archeomagnetic point of view. The new data were obtained from 9 kilns excavated in South Uzbekistan, with ages ranging from 200 BCE to 1429 CE. We then developed a regional update of the SHAWQ global models family by incorporating, for the first time, high-quality archeomagnetic data from Central Asia. The results indicate a relevant non-dipole feature presented over this region around the first century BCE.